Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Kantarjian
M. Kantarjian
Cancer research
Medicine
Mesylate
Chronic myelogenous leukemia
Imatinib
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
lymphocytic leukemia CD38 expression as an important prognostic factor in B-cell chronic
2013
M. Kantarjian
Maher Albitar
Sherif Ibrahim
M. J. Keating
Susan O'Brien
Yang O. Huh
Iman Jilani
Susan Lerner
Show All
Source
Cite
Save
Citations (0)
of early complete and major cytogenetic responses positive chronic myelogenous leukemia: high incidence - chromosome Imatinib mesylate therapy in newly diagnosed patients with Philadelphia
2013
Moshe Talpaz
Stefan Faderl
Deborah A. Thomas
Sima Jeha
Mary Beth Rios
Laurie Letvak
Kathy Bochinski
M. Kantarjian
Jorge Cortes
Susan O'Brien
Francis J. Giles
Guillermo Garcia-Manero
Show All
Source
Cite
Save
Citations (0)
chronic myelogenous leukemia in blast phase positive - Imatinib mesylate (STI571) therapy for Philadelphia chromosome
2013
Jianqin Shan
Stefan Faderl
Guillermo Garcia-Manero
Deborah A. Thomas
Debra Resta
M. Kantarjian
Jorge Cortes
Susan O'Brien
Francis J. Giles
Maher Albitar
Mary Beth Rios
Show All
Source
Cite
Save
Citations (0)
1